Deacom's AutoFinisher automates serialized and catch weight production
![](/46/pdcnewsitem/04/12/36/deacom.png)
New AutoFinisher moves manufacturing jobs from scale to label in under one second.
Deacom has launched its new AutoFinisher tool as part of its core ERP solution. Now process manufacturers of serialized or catch-weight products can efficiently weigh, serialize, label, palletize and report on production all within one, cohesive platform. Achieving this level of automation is particularly valuable for food and pharmaceutical industries where serialized and catch weight production adds complexity to the manufacturing process.
"There is a big push towards manufacturing automation and we believe that ERP solutions should play a key role in influencing this movement," said Scott Deakins, COO of Deacom. "By developing such capabilities that are native to our single-system ERP software, like the AutoFinisher, we are able to help support our customers in this progression. In fact, Deacom customers who are already using this feature have experienced drastic improvements in production efficiencies and results. This enhancement is just one example of Deacom's dedication towards the continuous product advancements designed to further enable the scalability of manufacturing companies."
Deacom's single-system ERP architecture allows the AutoFinisher to access and generate real-time data in the ERP platform. This is in sharp contrast to traditional ERP systems, which rely on heavy customizations and bolt-ons to support an entire business, including AutoFinisher-like capabilities. As more modules and customizations are implemented, the level of complexity begins to restrict business growth.
By building the AutoFinisher directly into the core Deacom ERP software, the benefits to customers are significant:
For companies in the pharmaceutical industry where production lines run well over 100 units per minute, sustaining this rate while adhering to new regulatory demands is of great concern. The Deacom AutoFinisher is able to generate serial number information and print relevant labels at unit, case, and pallet levels without affecting production speed.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance